skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

472 Total results for product and free and sample content found

Medtech Insight

Starts & Stops: New Trial Starts Led By Peripheral Vascular Interventions

By Reed Miller 26 May 2017

Starts & Stops is a regular feature highlighting Medtech Insight editors' picks of noteworthy medtech clinical trial initiations, completions and suspensions the past month or so.

Topic Medtech

Medtech Insight

45% Leap In Notified-Body Certificates Withdrawn From Device Firms

26 May 2017

2016 saw the largest single-year rise in the number of EU certificates that were withdrawn from device companies by members of the TEAM-NB notified body association.

Topic Medtech

Scrip

Scrip Asks… Is The Biosimilar Cost-Saving Theory Sustainable?

By Lucie Ellis 25 May 2017

Scrip asks industry whether the promise of biosimilars producing substantial cost-savings is a sustainable model to help healthcare systems afford the next wave of expensive biologics.

Topic Biosimilars

Scrip

Bioverativ Fills Gap In Pipeline With $400m True North Buy

By Mandy Jackson 25 May 2017

Bioverativ revealed its first transaction since spinning out from Biogen with the acquisition of True North for $400m plus up to $425m in milestone payments.

Topic Business strategies

Scrip

The Pharma Pipeline Report Card 2017, An Infographic

By Alex Shimmings 25 May 2017

The Pharmaceutical and Biotech industries’ R&D performance can be measured in a number of ways. View the infographic here.

Topic Research

Pink Sheet

Contrave TV Ad's Slimmed Down Adverse Events Draw FDA Rebuke

By Brenda Sandburg 25 May 2017

Referencing opioids and suicidal thoughts is not sufficient, US regulators say; letter comes as Orexigen has seen an upsurge in Contrave prescriptions.

Topic FDA

Pink Sheet

Getting On – And Staying In – the EMA’s PRIME Scheme

By Neena ​ Brizmohun 25 May 2017

Companies won’t necessarily lose their place on the European Medicines Agency’s priority medicines scheme if a competing product gets to market first.

Pink Sheet

Puma’s Neratinib Brings Uncertain Efficacy, Tolerability Concerns To FDA Panel

By Sue Sutter 23 May 2017

Tyrosine kinase inhibitor has an effect in adjuvant breast cancer but ‘there remains some uncertainty regarding the true magnitude of the treatment effect,”...

Topic Drug review

Pink Sheet

Emmaus Needs US FDA Advisory Cmte. To Rescue Sickle Cell Disease Candidate

By Michael Cipriano 23 May 2017

FDA reviewers disagree with Emmaus' extrapolation methods for holes in data for its L-glutamine ahead of May 24 Oncologic Drugs Advisory Committee meeting.

Topic Clinical trials

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: